Eto H - Search Results

1

Induction of apoptosis by low-molecular-weight fucoidan through calcium- and caspase-dependent mitochondrial pathways in MDA-MB-231 breast cancer cells.

Zhang Z, Teruya K, Eto H, Shirahata S. Zhang Z, et al. Among authors: eto h. Biosci Biotechnol Biochem. 2013;77(2):235-42. doi: 10.1271/bbb.120631. Epub 2013 Feb 7. Biosci Biotechnol Biochem. 2013. PMID: 23391903

2

Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in MDA-MB-231 and MCF-7 breast cancer cells.

Zhang Z, Teruya K, Yoshida T, Eto H, Shirahata S. Zhang Z, et al. Among authors: eto h. Mar Drugs. 2013 Jan 9;11(1):81-98. doi: 10.3390/md11010081. Mar Drugs. 2013. PMID: 23303302 Free PMC article.

3

Selective Suppression of Cell Growth and Programmed Cell Death-Ligand 1 Expression in HT1080 Fibrosarcoma Cells by Low Molecular Weight Fucoidan Extract.

Teruya K, Kusumoto Y, Eto H, Nakamichi N, Shirahata S. Teruya K, et al. Among authors: eto h. Mar Drugs. 2019 Jul 19;17(7):421. doi: 10.3390/md17070421. Mar Drugs. 2019. PMID: 31331053 Free PMC article.

4

Enzyme-digested Fucoidan Extracts Derived from Seaweed Mozuku of Cladosiphon novae-caledoniae kylin Inhibit Invasion and Angiogenesis of Tumor Cells.

Ye J, Li Y, Teruya K, Katakura Y, Ichikawa A, Eto H, Hosoi M, Hosoi M, Nishimoto S, Shirahata S. Ye J, et al. Among authors: eto h. Cytotechnology. 2005 Jan;47(1-3):117-26. doi: 10.1007/s10616-005-3761-8. Cytotechnology. 2005. PMID: 19003051 Free PMC article.

5

Fucoidan extract induces apoptosis in MCF-7 cells via a mechanism involving the ROS-dependent JNK activation and mitochondria-mediated pathways.

Zhang Z, Teruya K, Eto H, Shirahata S. Zhang Z, et al. Among authors: eto h. PLoS One. 2011;6(11):e27441. doi: 10.1371/journal.pone.0027441. Epub 2011 Nov 11. PLoS One. 2011. PMID: 22096572 Free PMC article.

6

Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer.

Miyake H, Hanada N, Nakamura H, Kagawa S, Fujiwara T, Hara I, Eto H, Gohji K, Arakawa S, Kamidono S, Saya H. Miyake H, et al. Among authors: eto h. Oncogene. 1998 Feb 19;16(7):933-43. doi: 10.1038/sj.onc.1201602. Oncogene. 1998. PMID: 9484785

7

Synergistic antitumor activity by combined treatment with gemcitabine and antisense oligodeoxynucleotide targeting clusterin gene in an intravesical administration model against human bladder cancer kotcc-1 cells.

Miyake H, Eto H, Hara I, So A, Li D, Gleave ME. Miyake H, et al. Among authors: eto h. J Urol. 2004 Jun;171(6 Pt 1):2477-81. doi: 10.1097/01.ju.0000118382.89456.f7. J Urol. 2004. PMID: 15126879

8

Introduction of insulin-like growth factor binding protein-2 gene into human bladder cancer cells enhances their metastatic potential.

Miyake H, Hara I, Yamanaka K, Muramaki M, Gleave M, Eto H. Miyake H, et al. Among authors: eto h. Oncol Rep. 2005 Feb;13(2):341-5. Oncol Rep. 2005. PMID: 15643522

9

Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen.

Miyake H, Hara I, Gleave ME, Eto H. Miyake H, et al. Among authors: eto h. Prostate. 2004 Dec 1;61(4):318-23. doi: 10.1002/pros.20087. Prostate. 2004. PMID: 15389725

10

[Ectopic production of HCG beta by bladder carcinoma in vitro and in vivo].

Morisue K, Yamanaka N, Eto H, Kamidono S, Nishimura R. Morisue K, et al. Among authors: eto h. Nihon Hinyokika Gakkai Zasshi. 1996 Mar;87(3):643-9. doi: 10.5980/jpnjurol1989.87.643. Nihon Hinyokika Gakkai Zasshi. 1996. PMID: 8709440 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results